869 related articles for article (PubMed ID: 35618017)
1. Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study.
Peng H; Wang S; Wang M; Ye Y; Xue E; Chen X; Wang X; Fan M; Gao W; Qin X; Wu Y; Chen D; Li J; Hu Y; Wang L; Wu T
Metabolism; 2022 Aug; 133():155220. PubMed ID: 35618017
[TBL] [Abstract][Full Text] [Related]
2. A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones.
Li X; Xie Y; Tang L; Li D; Wang J; Sheng H; Chen K; Xiao S; Li J; Yang M
Front Endocrinol (Lausanne); 2023; 14():1343367. PubMed ID: 38269249
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease and stroke: A Mendelian randomization study.
Wu M; Zha M; Lv Q; Xie Y; Yuan K; Zhang X; Liu X
Eur J Neurol; 2022 May; 29(5):1534-1537. PubMed ID: 35147274
[TBL] [Abstract][Full Text] [Related]
4. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Li S; Fu Y; Liu Y; Zhang X; Li H; Tian L; Zhuo L; Liu M; Cui J
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3497-e3503. PubMed ID: 35363278
[TBL] [Abstract][Full Text] [Related]
5. Causal Association Between Anemia and Cardiovascular Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Gan T; Hu J; Liu W; Li C; Xu Q; Wang Y; Lu S; Aledan AKO; Wang Y; Wang Z
J Am Heart Assoc; 2023 Jun; 12(12):e029689. PubMed ID: 37301769
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians.
Au Yeung SL; Borges MC; Wong THT; Lawlor DA; Schooling CM
Int J Epidemiol; 2023 Jun; 52(3):921-931. PubMed ID: 36367831
[TBL] [Abstract][Full Text] [Related]
7. Serum 25-hydroxyvitamin D levels and the risk of non-alcoholic fatty liver: A two-sample Mendelian randomization study.
Sheng Q; Shi H; Liu S; Zhuang L; Zhao Z; Xin Y
Saudi J Gastroenterol; 2023; 29(1):39-46. PubMed ID: 36254930
[TBL] [Abstract][Full Text] [Related]
8. Telomere length and the risk of cardiovascular diseases: A Mendelian randomization study.
Deng Y; Li Q; Zhou F; Li G; Liu J; Lv J; Li L; Chang D
Front Cardiovasc Med; 2022; 9():1012615. PubMed ID: 36352846
[TBL] [Abstract][Full Text] [Related]
9. Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study.
Bell S; Gibson JT; Harshfield EL; Markus HS
Atherosclerosis; 2020 Nov; 313():111-117. PubMed ID: 33038664
[TBL] [Abstract][Full Text] [Related]
10. Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study.
Tao M; Zhou G; Liu J; He M; Wang C; Luo X; Zhang L
Clin Endocrinol (Oxf); 2023 Oct; 99(4):370-377. PubMed ID: 37559547
[TBL] [Abstract][Full Text] [Related]
11. Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study.
Liu Z; Wang H; Yang Z; Lu Y; Zou C
Cardiovasc Diabetol; 2023 Sep; 22(1):236. PubMed ID: 37659996
[TBL] [Abstract][Full Text] [Related]
12. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
[TBL] [Abstract][Full Text] [Related]
13. Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study.
Zhang Z; Burrows K; Fuller H; Speliotes EK; Abeysekera KWM; Thorne JL; Lewis SJ; Zulyniak MA; Moore JB
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986172
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Glycated Hemoglobin (HbA
Au Yeung SL; Luo S; Schooling CM
Diabetes Care; 2018 Sep; 41(9):1991-1997. PubMed ID: 29950300
[TBL] [Abstract][Full Text] [Related]
15. The impact of plasma vitamin C levels on the risk of cardiovascular diseases and Alzheimer's disease: A Mendelian randomization study.
Chen L; Sun X; Wang Z; Lu Y; Chen M; He Y; Xu H; Zheng L
Clin Nutr; 2021 Oct; 40(10):5327-5334. PubMed ID: 34537655
[TBL] [Abstract][Full Text] [Related]
16. Use of Mendelian randomization to evaluate the effect of atrial fibrillation on cardiovascular diseases and cardiac death.
Hu M; Tan J; Yang J; Gao X; Yang Y
ESC Heart Fail; 2023 Feb; 10(1):628-636. PubMed ID: 36404673
[TBL] [Abstract][Full Text] [Related]
17. Narcolepsy and cardiovascular disease: A two-sample Mendelian randomization study.
Tao Y; Luo J; Xu Y; Wang H; Tian J; Yang S; Yu K; Peng S; Zhang X
Sleep Med; 2024 Jan; 113():6-12. PubMed ID: 37976908
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus and the risk of cardiovascular diseases: A two-sample Mendelian randomization study.
Huang S; Huang F; Mei C; Tian F; Fan Y; Bao J
Front Cardiovasc Med; 2022; 9():896499. PubMed ID: 36119739
[TBL] [Abstract][Full Text] [Related]
19. Investigating the association of atopic dermatitis with ischemic stroke and coronary heart disease: A mendelian randomization study.
Huang J; Gui Y; Wu J; Xie Y
Front Genet; 2022; 13():956850. PubMed ID: 36110212
[No Abstract] [Full Text] [Related]
20. Relationship between NAFLD and coronary artery disease: A Mendelian randomization study.
Ren Z; Simons PIHG; Wesselius A; Stehouwer CDA; Brouwers MCGJ
Hepatology; 2023 Jan; 77(1):230-238. PubMed ID: 35441719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
